Minimally Invasive and Regenerative Therapeutics

Nureddin Ashammakhi, Samad Ahadian, Mohammad Ali Darabi, Mario El Tahchi, Junmin Lee, Kasinan Suthiwanich, Amir Sheikhi, Mehmet R. Dokmeci, Rahmi Oklu, Ali Khademhosseini

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Advances in biomaterial synthesis and fabrication, stem cell biology, bioimaging, microsurgery procedures, and microscale technologies have made minimally invasive therapeutics a viable tool in regenerative medicine. Therapeutics, herein defined as cells, biomaterials, biomolecules, and their combinations, can be delivered in a minimally invasive way to regenerate different tissues in the body, such as bone, cartilage, pancreas, cardiac, skeletal muscle, liver, skin, and neural tissues. Sophisticated methods of tracking, sensing, and stimulation of therapeutics in vivo using nano-biomaterials and soft bioelectronic devices provide great opportunities to further develop minimally invasive and regenerative therapeutics (MIRET). In general, minimally invasive delivery methods offer high yield with low risk of complications and reduced costs compared to conventional delivery methods. Here, minimally invasive approaches for delivering regenerative therapeutics into the body are reviewed. The use of MIRET to treat different tissues and organs is described. Although some clinical trials have been performed using MIRET, it is hoped that such therapeutics find wider applications to treat patients. Finally, some future perspective and challenges for this emerging field are highlighted.

Original languageEnglish (US)
Article number1804041
JournalAdvanced Materials
Volume31
Issue number1
DOIs
StatePublished - Jan 4 2019

Fingerprint

Biocompatible Materials
Biomaterials
Tissue
Cytology
Cartilage
Biomolecules
Stem cells
Liver
Muscle
Skin
Bone
Fabrication
Costs

Keywords

  • biomaterials
  • biomolecules
  • delivery
  • minimally invasive
  • scaffolds
  • tissue regeneration

ASJC Scopus subject areas

  • Materials Science(all)
  • Mechanics of Materials
  • Mechanical Engineering

Cite this

Ashammakhi, N., Ahadian, S., Darabi, M. A., El Tahchi, M., Lee, J., Suthiwanich, K., ... Khademhosseini, A. (2019). Minimally Invasive and Regenerative Therapeutics. Advanced Materials, 31(1), [1804041]. https://doi.org/10.1002/adma.201804041

Minimally Invasive and Regenerative Therapeutics. / Ashammakhi, Nureddin; Ahadian, Samad; Darabi, Mohammad Ali; El Tahchi, Mario; Lee, Junmin; Suthiwanich, Kasinan; Sheikhi, Amir; Dokmeci, Mehmet R.; Oklu, Rahmi; Khademhosseini, Ali.

In: Advanced Materials, Vol. 31, No. 1, 1804041, 04.01.2019.

Research output: Contribution to journalReview article

Ashammakhi, N, Ahadian, S, Darabi, MA, El Tahchi, M, Lee, J, Suthiwanich, K, Sheikhi, A, Dokmeci, MR, Oklu, R & Khademhosseini, A 2019, 'Minimally Invasive and Regenerative Therapeutics' Advanced Materials, vol. 31, no. 1, 1804041. https://doi.org/10.1002/adma.201804041
Ashammakhi N, Ahadian S, Darabi MA, El Tahchi M, Lee J, Suthiwanich K et al. Minimally Invasive and Regenerative Therapeutics. Advanced Materials. 2019 Jan 4;31(1). 1804041. https://doi.org/10.1002/adma.201804041
Ashammakhi, Nureddin ; Ahadian, Samad ; Darabi, Mohammad Ali ; El Tahchi, Mario ; Lee, Junmin ; Suthiwanich, Kasinan ; Sheikhi, Amir ; Dokmeci, Mehmet R. ; Oklu, Rahmi ; Khademhosseini, Ali. / Minimally Invasive and Regenerative Therapeutics. In: Advanced Materials. 2019 ; Vol. 31, No. 1.
@article{75660ae4fc9d4f58a3625894cbf84669,
title = "Minimally Invasive and Regenerative Therapeutics",
abstract = "Advances in biomaterial synthesis and fabrication, stem cell biology, bioimaging, microsurgery procedures, and microscale technologies have made minimally invasive therapeutics a viable tool in regenerative medicine. Therapeutics, herein defined as cells, biomaterials, biomolecules, and their combinations, can be delivered in a minimally invasive way to regenerate different tissues in the body, such as bone, cartilage, pancreas, cardiac, skeletal muscle, liver, skin, and neural tissues. Sophisticated methods of tracking, sensing, and stimulation of therapeutics in vivo using nano-biomaterials and soft bioelectronic devices provide great opportunities to further develop minimally invasive and regenerative therapeutics (MIRET). In general, minimally invasive delivery methods offer high yield with low risk of complications and reduced costs compared to conventional delivery methods. Here, minimally invasive approaches for delivering regenerative therapeutics into the body are reviewed. The use of MIRET to treat different tissues and organs is described. Although some clinical trials have been performed using MIRET, it is hoped that such therapeutics find wider applications to treat patients. Finally, some future perspective and challenges for this emerging field are highlighted.",
keywords = "biomaterials, biomolecules, delivery, minimally invasive, scaffolds, tissue regeneration",
author = "Nureddin Ashammakhi and Samad Ahadian and Darabi, {Mohammad Ali} and {El Tahchi}, Mario and Junmin Lee and Kasinan Suthiwanich and Amir Sheikhi and Dokmeci, {Mehmet R.} and Rahmi Oklu and Ali Khademhosseini",
year = "2019",
month = "1",
day = "4",
doi = "10.1002/adma.201804041",
language = "English (US)",
volume = "31",
journal = "Advanced Materials",
issn = "0935-9648",
publisher = "Wiley-VCH Verlag",
number = "1",

}

TY - JOUR

T1 - Minimally Invasive and Regenerative Therapeutics

AU - Ashammakhi, Nureddin

AU - Ahadian, Samad

AU - Darabi, Mohammad Ali

AU - El Tahchi, Mario

AU - Lee, Junmin

AU - Suthiwanich, Kasinan

AU - Sheikhi, Amir

AU - Dokmeci, Mehmet R.

AU - Oklu, Rahmi

AU - Khademhosseini, Ali

PY - 2019/1/4

Y1 - 2019/1/4

N2 - Advances in biomaterial synthesis and fabrication, stem cell biology, bioimaging, microsurgery procedures, and microscale technologies have made minimally invasive therapeutics a viable tool in regenerative medicine. Therapeutics, herein defined as cells, biomaterials, biomolecules, and their combinations, can be delivered in a minimally invasive way to regenerate different tissues in the body, such as bone, cartilage, pancreas, cardiac, skeletal muscle, liver, skin, and neural tissues. Sophisticated methods of tracking, sensing, and stimulation of therapeutics in vivo using nano-biomaterials and soft bioelectronic devices provide great opportunities to further develop minimally invasive and regenerative therapeutics (MIRET). In general, minimally invasive delivery methods offer high yield with low risk of complications and reduced costs compared to conventional delivery methods. Here, minimally invasive approaches for delivering regenerative therapeutics into the body are reviewed. The use of MIRET to treat different tissues and organs is described. Although some clinical trials have been performed using MIRET, it is hoped that such therapeutics find wider applications to treat patients. Finally, some future perspective and challenges for this emerging field are highlighted.

AB - Advances in biomaterial synthesis and fabrication, stem cell biology, bioimaging, microsurgery procedures, and microscale technologies have made minimally invasive therapeutics a viable tool in regenerative medicine. Therapeutics, herein defined as cells, biomaterials, biomolecules, and their combinations, can be delivered in a minimally invasive way to regenerate different tissues in the body, such as bone, cartilage, pancreas, cardiac, skeletal muscle, liver, skin, and neural tissues. Sophisticated methods of tracking, sensing, and stimulation of therapeutics in vivo using nano-biomaterials and soft bioelectronic devices provide great opportunities to further develop minimally invasive and regenerative therapeutics (MIRET). In general, minimally invasive delivery methods offer high yield with low risk of complications and reduced costs compared to conventional delivery methods. Here, minimally invasive approaches for delivering regenerative therapeutics into the body are reviewed. The use of MIRET to treat different tissues and organs is described. Although some clinical trials have been performed using MIRET, it is hoped that such therapeutics find wider applications to treat patients. Finally, some future perspective and challenges for this emerging field are highlighted.

KW - biomaterials

KW - biomolecules

KW - delivery

KW - minimally invasive

KW - scaffolds

KW - tissue regeneration

UR - http://www.scopus.com/inward/record.url?scp=85058820883&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058820883&partnerID=8YFLogxK

U2 - 10.1002/adma.201804041

DO - 10.1002/adma.201804041

M3 - Review article

VL - 31

JO - Advanced Materials

JF - Advanced Materials

SN - 0935-9648

IS - 1

M1 - 1804041

ER -